Member Directory

Snoretox Pty Ltd

Member Contact: Tony Sasse

Position: Managing Director

Industry: Biotech & Pharmaceuticals

Company Profile:

At Snoretox, we have developed novel tetanus toxin based biotherapeutics for the treatment of conditions by the controlled increase of local muscle tone. These include Snoring, Obstructive Sleep Apnoea, Ectropion, cosmetic indications, anal incontinence, and neurological muscle disorders in animals and humans. Snoretox has previously demonstrated the ability to treat sleep apnea with tetanus toxin in an animal model of the disease, the British bulldog. The innovations we have made at Snoretox, were to develop and patent technologies and modifications of tetanus toxin that enables it to function in an individual that is vaccinated against tetanus, unlocking the immense therapeutic, cosmetic and veterinary potential of the tetanus toxin.

Home

News & opinion

Events

CLICK HERE TO SUBSCRIBE TO OUR NEWSLETTER

BioMelbourne Network respectfully acknowledges the Traditional Custodians of the unceded lands and waters of Victoria: the Bunurong, Gunaikurnai and Wurundjeri peoples, on which the BioMelbourne Network and our Victorian members work, and as well as the lands and waters of our members further afield. We pay respect to their Elders past and present. As Australia’s first scientists, we acknowledge the significant contribution that they and other Aboriginal and Torres Strait Islander people have made and continue to make to the research and knowledge systems that inform our community and our sector.

We acknowledge that Aboriginal and Torres Strait Islander people continue to live in a spiritual and sacred relationship with this country and recognise our responsibility to continue to work towards reconciliation.